Project Details
Description
A Phase III Randomized Double-Blind, Placebo-Controlled Study Examining the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine
| Status | Finished |
|---|---|
| Effective start/end date | 5/2/07 → 10/30/08 |
Funding
- Altus Pharmaceuticals Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.